Institutional & Family Asset Management’s Immunogen Inc IMGN Stock Holding History

Institutional & Family Asset Management’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-667	Closed	-$3K	–	787
2022 Q3	$3K	Hold	667	–	–	﹤0.01%	568
2022 Q2	$3K	Hold	667	–	–	﹤0.01%	576
2022 Q1	$3K	Sell	667 -24	-3%	-$133	﹤0.01%	627
2021 Q4	$5K	Hold	691	–	–	﹤0.01%	576
2021 Q3	$4K	Hold	691	–	–	﹤0.01%	719
2021 Q2	$5K	Hold	691	–	–	﹤0.01%	732
2021 Q1	$6K	Hold	691	–	–	﹤0.01%	674
2020 Q4	$4K	Hold	691	–	–	﹤0.01%	685
2020 Q3	$2K	Hold	691	–	–	﹤0.01%	744
2020 Q2	$3K	Sell	691 -31	-4%	-$132	﹤0.01%	665
2020 Q1	$2K	Hold	722	–	–	﹤0.01%	685
2019 Q4	$4K	Sell	722 -1	-0.1%	-$3	﹤0.01%	635
2019 Q3	$2K	Buy	723 +17	+2%	+$45	﹤0.01%	742
2019 Q2	$2K	Hold	706	–	–	﹤0.01%	758
2019 Q1	$2K	Hold	706	–	–	﹤0.01%	749
2018 Q4	$3K	Hold	706	–	–	﹤0.01%	659
2018 Q3	$7K	Hold	706	–	–	﹤0.01%	585
2018 Q2	$7K	Hold	706	–	–	﹤0.01%	584
2018 Q1	$7K	Buy	+706	New	+$6.97K	﹤0.01%	564

Other funds holding IMGN

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Institutional & Family Asset Management's IMGN Position: Q4 2022 in Review

Institutional & Family Asset Management sold out of Immunogen Inc (IMGN) in Q4 2022, closing a stake of 667 shares — an estimated $3K sold.

Institutional & Family Asset Management first reported a position in IMGN in Q1 2018 and held it in 19 quarters. The position peaked at $7K in Q3 2018. 204 funds tracked by Wall St. Rank hold IMGN as of Q4 2022.

Institutional & Family Asset Management reported no remaining Immunogen Inc position as of Q4 2022 after selling out during the quarter.
Institutional & Family Asset Management sold 667 Immunogen Inc shares in Q4 2022, an estimated $3K.
Institutional & Family Asset Management first reported a position in Immunogen Inc in Q1 2018 and held it in 19 quarters.
Institutional & Family Asset Management's Immunogen Inc position peaked at $7K in Q3 2018.
204 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2022.

Based on Institutional & Family Asset Management's 13F filing for Q4 2022, filed 8 Feb 2023.